GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
3.490
-0.040 (-1.13%)
Aug 31, 2026, 3:20 PM EDT - Market open
GoodRx Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 785.23 | 796.85 | 792.32 | 750.27 | 766.55 | 745.42 | |
Revenue Growth | -1.83% | 0.57% | 5.61% | -2.13% | 2.83% | 35.36% |
Cost of Revenue | 72.04 | 57.6 | 48.22 | 62.43 | 65.08 | 46.72 |
Gross Profit | 713.19 | 739.26 | 744.11 | 687.84 | 701.48 | 698.71 |
Selling, General & Admin | 422.18 | 430.52 | 464.62 | 450.94 | 484.37 | 524.9 |
Research & Development | 113.14 | 117.33 | 123.75 | 126.44 | 143.14 | 125.86 |
Operating Expenses | 623.95 | 633.06 | 657.91 | 638.34 | 681.68 | 685.3 |
Operating Income | 89.24 | 106.2 | 86.2 | 49.5 | 19.8 | 13.41 |
Interest Expense | -40.81 | -42.61 | -52.92 | -56.73 | -34.24 | -23.64 |
Interest & Investment Income | 6.61 | 10.93 | 23.27 | 32.17 | 9.27 | 0.06 |
Other Non Operating Income (Expenses) | 0.65 | 0.72 | -2.66 | -4.01 | - | - |
EBT Excluding Unusual Items | 55.69 | 75.24 | 53.89 | 20.93 | -5.17 | -10.18 |
Merger & Restructuring Charges | -8.44 | -8.44 | -7.36 | -75.15 | - | - |
Asset Writedown | - | -4.41 | - | -1.35 | - | - |
Legal Settlements | -5.86 | -5.86 | -13 | - | - | - |
Other Unusual Items | - | - | -2.08 | - | -18.06 | - |
Pretax Income | 41.4 | 56.54 | 31.46 | -55.57 | -23.23 | -10.18 |
Income Tax Expense | 25.15 | 26.1 | 15.07 | -46.7 | 9.6 | 15.08 |
Net Income | 16.25 | 30.44 | 16.39 | -8.87 | -32.83 | -25.25 |
Net Income to Common | 16.25 | 30.44 | 16.39 | -8.87 | -32.83 | -25.25 |
Net Income Growth | -53.04% | 85.72% | - | - | - | - |
Shares Outstanding (Basic) | 342 | 356 | 386 | 410 | 413 | 410 |
Shares Outstanding (Diluted) | 345 | 357 | 392 | 410 | 413 | 410 |
Shares Change | -9.06% | -8.97% | -4.42% | -0.62% | 0.70% | 49.25% |
EPS (Basic) | 0.05 | 0.09 | 0.04 | -0.02 | -0.08 | -0.06 |
EPS (Diluted) | 0.05 | 0.09 | 0.04 | -0.02 | -0.08 | -0.06 |
EPS Growth | -46.78% | 113.56% | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 197.09 | 164.38 | 182.65 | 137.25 | 142.81 | 174.21 |
Free Cash Flow Per Share | 0.57 | 0.46 | 0.47 | 0.33 | 0.35 | 0.42 |
Gross Margin | 90.83% | 92.77% | 93.92% | 91.68% | 91.51% | 93.73% |
Operating Margin | 11.37% | 13.33% | 10.88% | 6.60% | 2.58% | 1.80% |
Profit Margin | 2.07% | 3.82% | 2.07% | -1.18% | -4.28% | -3.39% |
Free Cash Flow Margin | 25.10% | 20.63% | 23.05% | 18.29% | 18.63% | 23.37% |
EBITDA | 108.78 | 122.31 | 99.54 | 66.57 | 47.57 | 35.75 |
EBITDA Margin | 13.85% | 15.35% | 12.56% | 8.87% | 6.21% | 4.79% |
D&A For EBITDA | 19.54 | 16.12 | 13.34 | 17.07 | 27.78 | 22.34 |
EBIT | 89.24 | 106.2 | 86.2 | 49.5 | 19.8 | 13.41 |
EBIT Margin | 11.37% | 13.33% | 10.88% | 6.60% | 2.58% | 1.80% |
Effective Tax Rate | 60.75% | 46.16% | 47.90% | - | - | - |
Advertising Expenses | - | 203.3 | 211.4 | 198.8 | 226.3 | 296.6 |